News Column

The HUB Foundation for Organoid Technology and STEMCELL Technologies Inks Pact on the Manufacturing of Cell Culture Media for Organoids

January 23, 2014

The HUB Foundation for Organoid Technology said that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids.

In a release, HUB said that Organoids are mini-organs grown in tissue culture from small pieces of tissue derived from patients with cancer and other diseases, and represent an exciting new tool for scientific research and drug discovery and validation.

"We are pleased that STEMCELL will be our partner in making specialty media for growth of organoids available to the scientific community," said Prof. Hans Clevers, one of the founding directors of the HUB. "The broad availability of off-the-shelf cell culture media from a world leader in the development of specialized cell culture media and cell separation products represents an essential step in the further implementation of this exciting technology."

"We are delighted to bring these important culture media products quickly and reliably to researchers for the growth of tissue- specific organoids, and to be the exclusive commercial supplier," said Dr. Allen Eaves, CEO and President of STEMCELL Technologies. "The first product under this license will be released soon for culture of murine organoids, with products for human tissue to follow."

The HUB is a not-for-profit organization founded by the Royal Netherlands Academy of Sciences and the University Medical Center Utrecht.

STEMCELL Technologies Inc is a privately-owned biotechnology company that develops specialty cell culture media, cell separation products and ancillary reagents for life science research.

((Comments on this story may be sent to health@closeupmedia.com))


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Health & Beauty Close - Up


Story Tools